Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple MyelomaBlood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseRecruitingPhase 1 / Phase 22026-09-11NCT06049290

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Nanjing Leads Biolabs Co.,Ltd13

21 results · Page 1 of 1

Swipe the table sideways for more columns.